Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Champlin

Showing results (271-280 of 279) with videos related to

Pageof 28
Sort By:
You have reached the last page of results.This site can display upto 279 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 14, 2019
Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell TransplantationPiyanuch Kongtim, Omar Hasan, Jorge Miguel Ramos Perez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2000
Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1D Przepiorka, R Saliba, K Cleary, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 8, 1999
Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of acute leukemia and lymphomaK A Margolin, K Van Besien, C Wright, et al.
Leukemia|July 21, 2017
Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activityE Liu, Y Tong, G Dotti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 1997
The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantationJ Gajewski, D Gjertson, M Cecka, et al.
Cytotherapy|April 30, 2010
Long-term outcome of a phase II study of BM transplants, partially depleted ex-vivo of CD5-positive and CD8-positive T-lymphocytes in unrelated and related donor 1 antigen mismatched recipientsJ L Gajewski, S Nimer, R M Saliba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancerZ Rahman, J Kavanagh, R Champlin, et al.
Leukemia|April 3, 2013
Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trialM Wang, N Fowler, N Wagner-Bartak, et al.
Blood|May 23, 1998
A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantationS H Bernstein, A P Nademanee, J M Vose, et al.
Pageof 28

Showing results (271-280 of 279) with videos related to

Sort By:
Pageof 28
You have reached the last page of results.This site can display upto 279 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 14, 2019
Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell TransplantationPiyanuch Kongtim, Omar Hasan, Jorge Miguel Ramos Perez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2000
Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1D Przepiorka, R Saliba, K Cleary, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 8, 1999
Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of acute leukemia and lymphomaK A Margolin, K Van Besien, C Wright, et al.
Leukemia|July 21, 2017
Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activityE Liu, Y Tong, G Dotti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 1997
The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantationJ Gajewski, D Gjertson, M Cecka, et al.
Cytotherapy|April 30, 2010
Long-term outcome of a phase II study of BM transplants, partially depleted ex-vivo of CD5-positive and CD8-positive T-lymphocytes in unrelated and related donor 1 antigen mismatched recipientsJ L Gajewski, S Nimer, R M Saliba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancerZ Rahman, J Kavanagh, R Champlin, et al.
Leukemia|April 3, 2013
Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trialM Wang, N Fowler, N Wagner-Bartak, et al.
Blood|May 23, 1998
A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantationS H Bernstein, A P Nademanee, J M Vose, et al.
Pageof 28